Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1002/anie.201603178 http://scihub22266oqcxt.onion/10.1002/anie.201603178 C5089616!5089616!27295499     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Angew+Chem+Int+Ed+Engl 2016 ; 55 (32): 9411-5 Nephropedia Template TP {{tp|p=27295499|t=2016. GM1 Ganglioside Inhibits ??Amyloid Oligomerization Induced by Sphingomyelin |pdf=|usr=}}{{27295499}} gab.com Text GM1 Ganglioside Inhibits Amyloid Oligomerization Induced by Sphingomyelin JO: Angew Chem Int Ed Engl http://www.kidney.de/pget.php?&tw=1&pmid=27295499 #FOAvip ??Amyloid (A?) oligomers are neurotoxic and implicated in Alzheimer's disease. Neuronal plasma membranes may mediate formation of A? oligomers in vivo. Membrane components sphingomyelin and GM1 have been shown to promote aggregation of A?; however, these studies were performed under extreme, non?physiological conditions. We demonstrate that physiological levels of GM1, organized in nanodomains do not seed oligomerization of A?40 monomers. We show that sphingomyelin triggers oligomerization of A?40 and that GM1 is counteractive thus preventing oligomerization. We propose a molecular explanation that is supported by all?atom molecular dynamics simulations. The preventive role of GM1 in the oligomerization of A?40 suggests that decreasing levels of GM1 in the brain, for example, due to aging, could reduce protection against A? oligomerization and contribute to the onset of Alzheimer's disease. Twit Text FOAVip GM1 Ganglioside Inhibits Amyloid Oligomerization Induced by Sphingomyelin ????Angew Chem Int Ed Engl http://www.kidney.de/pget.php?&tw=1&pmid=27295499 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=27295499 #FOAvip English Wikipedia <ref>{{Cite pmid|27295499}}</ref> GM1 Ganglioside Inhibits ??Amyloid Oligomerization Induced by Sphingomyelin #MMPMID27295499 Amaro M; ?achl R; Aydogan G; Mikhalyov II; Vácha R; Hof M Angew Chem Int Ed Engl 2016[Aug]; 55 (32): 9411-5 PMID27295499show ga ??Amyloid (A?) oligomers are neurotoxic and implicated in Alzheimer's disease. Neuronal plasma membranes may mediate formation of A? oligomers in vivo. Membrane components sphingomyelin and GM1 have been shown to promote aggregation of A?; however, these studies were performed under extreme, non?physiological conditions. We demonstrate that physiological levels of GM1, organized in nanodomains do not seed oligomerization of A?40 monomers. We show that sphingomyelin triggers oligomerization of A?40 and that GM1 is counteractive thus preventing oligomerization. We propose a molecular explanation that is supported by all?atom molecular dynamics simulations. The preventive role of GM1 in the oligomerization of A?40 suggests that decreasing levels of GM1 in the brain, for example, due to aging, could reduce protection against A? oligomerization and contribute to the onset of Alzheimer's disease. äGM1 Ganglioside Inhibits ??Amyloid Oligomerization Induced by Sphingom(epmc).pdf DeepDyve Pubget Overpricing